newsfilter
← Latest News
GlobeNewswire·

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI

Vancouver, Canada, July 07, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic,